Recent Securities Litigations

Longeveron Inc. Class A Common Stock (NASDAQ: LGVN)

27 Days left to seek lead plaintiff status.

Company Name:Longeveron Inc. Class A Common Stock
Stock Symbol:NASDAQ: LGVN
Class Period Start:02/12/2021
Class Period End (inclusive):08/12/2021
Filing Deadline:11/12/2021

The Complaint alleges that the Offering Documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Specifically, the Complaint alleges that the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that: (i) Lomecel-B was not as effective in treating aging frailty as Defendants had led investors to believe; (ii) accordingly, Lomecel-B's clinical and commercial prospects with respect to aging frailty were overstated; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

Longeveron Inc. Class A Common Stock (NASDAQ: LGVN) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.